Chargement en cours...
Gabapentin for the Management of Hot Flashes in Prostate Cancer Survivors: A Longitudinal Continuation Study – NCCTG Trial N00CB
BACKGROUND: Hot flashes are a complication of androgen deprivation therapy given to men with prostate cancer. A previous clinical study indicated that use of low dose gabapentin (900mg/day) was well-tolerated and decreased hot flash frequency to a moderate degree for 4 weeks. The purpose of this cur...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3075822/ https://ncbi.nlm.nih.gov/pubmed/20552926 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|